Navigation Links
(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
Date:12/15/2008

ABBOTT PARK, Ill., Dec. 15 /PRNewswire-FirstCall/ -- Today, the U.S. Food and Drug Administration (FDA) approved Abbott's TRILIPIX(TM) (fenofibric acid) delayed-release capsules for use along with diet to help lower triglycerides and LDL cholesterol, and to raise HDL cholesterol in patients with lipid problems. TRILIPIX is the first and only fibrate to be approved for use in combination with a statin. In certain patients, treatment guidelines recommend the combination of a fibrate with a statin to further improve lipid levels. TRILIPIX has not been shown to prevent heart disease or heart attack.


    To view the Multimedia News Release, go to:
http://www.prnewswire.com/mnr/abbott/35271/

"Only 35 percent of patients with lipid problems are currently being treated with lipid therapies and many are not reaching treatment targets for all three key lipids," said Michael Davidson, M.D., clinical professor and director of Preventive Cardiology, University of Chicago Pritzker School of Medicine. "The approval of TRILIPIX is good news for patients because now there is a new treatment option that can be used alone or in combination with a statin to help address lipid problems."

TRILIPIX was studied in 2,698 patients with mixed dyslipidemia, a disorder of all three key lipids affecting millions of American adults. In the TRILIPIX studies, mixed dyslipidemia was characterized by elevated LDL (bad cholesterol) and triglycerides (a type of fat found in the blood) and low HDL (good cholesterol). These studies demonstrated that TRILIPIX used in combination with the most commonly prescribed statins helped patients manage all three key lipids better than the corresponding therapies alone.

Treatment guidelines endorsed by the National Cholesterol Education Progra
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... One of the largest studies ever conducted into the ... new sites on chromosomes that harbor inherited genes tied ... team of researchers, now bring the total number of ... Although these schizophrenia-associated genes aren,t specific enough ... will or will not develop the illness, researchers say ...
(Date:7/22/2014)... July 22, 2014 CarePoint Health is pleased ... as the President of the medical staff at Bayonne Medical ... serve as President, as voted on by the physicians on ... medical staff in relation to the administration at Bayonne Medical ... physicians and to work to make the Medical Center the ...
(Date:7/22/2014)... The donation from the Edusei Foundation was greatly ... a feat of strategic engineering, such assistance tends to etch ... the beneficiaries. It provided a sense of family to them, ... Edusei Foundation donated various amounts of; milk, soap, ... , The Government of Ghana established the Kumasi Children’s Home ...
(Date:7/22/2014)... 2014 Hospitals & Health ... conducted by Hospitals & Health Networks in ... CareTech Solutions, The College of Healthcare Information ... list recognizes hospitals for successful health information ... in four focus areas: business and administrative ...
(Date:7/22/2014)... TUESDAY, July 22, 2014 (HealthDay News) -- People who ... risk for a rise in blood pressure, a new ... major health problems and even early death, but few ... trouble may be one of the causes, according to ... 138 people who had been separated or divorced for ...
Breaking Medicine News(10 mins):Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 3Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 4Health News:Sleepless Nights After Divorce May Be Tied to Blood Pressure Rise 2
... The Association for Research in Vision and Ophthalmology ... distinguished fellows. The title of Fellow of ARVO (FARVO) ... the Association. By accepting this honor, ARVO anticipates ... and mentors for individuals pursuing careers in vision and ...
... be important in cardiac development has been newly associated ... the left ventricular outflow tract. These are the findings ... appearing in the journal Birth Defects Research Part ... including aortic valve stenosis, coarctation of the aorta, hypoplastic ...
... tomography (PET) in patients with head and neck tumours, ... cannot currently be reliably assessed. This is the result ... for Quality and Efficiency in Health Care (IQWiG). The ... to assess the advantages and disadvantages of this diagnostic ...
... prostate-rectal inter-space is an effective way to reduce the ... according to research presented April 30, 2011, at the ... symposium is sponsored by the American Society for Radiation ... Even though prostate cancer is cured in over 90 ...
... Combining computerized tomography (CT) with fluorodeoxyglucose positron emission ... tumor outlines and potentially different treatment options in ... CT alone, according to research presented today, at ... Atlanta. This symposium is co-sponsored by the American ...
... of hospitalization have discouraged primary care doctors from seeing ... use of "hospitalists," a new physician specialty focused on ... field mean that frequently hospitalized patients also may need ... expert on hospital care at the University of Chicago. ...
Cached Medicine News:Health News:2011 ARVO Fellows announced 2Health News:Study identifies second gene associated with specific congenital heart defects 2Health News:Benefit of PET in patients with head and neck tumors cannot be assessed 2Health News:Benefit of PET in patients with head and neck tumors cannot be assessed 3Health News:Benefit of PET in patients with head and neck tumors cannot be assessed 4Health News:Tissue spacers reduce risk of rectal injury for prostate cancer patients 2Health News:Frequently hospitalized patients may benefit from new medical specialty focused on their needs 2
(Date:7/22/2014)... England , July 22, 2014 ... development and device company focused on solid dose ... its novel solid formulation of octreotide acetate achieved ... it with the currently marketed liquid product (Sandostatin®). ... transfer the formulation production process to a contract ...
(Date:7/21/2014)... /PRNewswire-iReach/ -- Nitrosolution.com, a website that features safe and ... first anniversary in August. The online retailer specializes in ... body,s ability to produce nitric oxide. Called Nitroxyl, it ... a variety of phytonutrients and other natural ingredients that ... nitric oxide production in the arteries and ...
(Date:7/21/2014)... , July 21, 2014 Thoratec Corporation (NASDAQ: ... mechanical circulatory support therapies to save, support and restore ... operating results for the second quarter of fiscal year ... will hold a conference call to discuss its financial ... at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern ...
Breaking Medicine Technology:Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2Thoratec Schedules Second Quarter Conference Call, Webcast 2
... 12 Lexicon,Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... drug (IND) application to the U.S. Food and ... for rheumatoid,arthritis and other autoimmune conditions. The initial ... a double-blind, randomized,placebo-controlled, ascending single-dose study in healthy ...
... Medical Lasers Limited,(ASX: ELX), a global leader in ... systems, announced today initial clinical results of,an ongoing ... demonstrate the therapy,s potential to improve and,stabilize visual ... with,diabetic maculopathy and macular edema without causing any ...
Cached Medicine Technology:Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 2Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 4
... To aid clinicians in performing Ankle/Brachial ... a new, complete packet of information. It ... presentation that can be viewed on any ... the step-by-step procedure of performing an ABI ...
... Auto Refractor/Keratometer. Advanced engineering, ... retro illumination mode make it the ... use. 5.5 inch High Quality ... focusing. Rapid, instantaneous readings are taken ...
... for Urinary Tract Infection (UTI) ... A multi-center study was conducted ... UTIs. There were 1,887 urine ... and nitrite results of Multistix ...
... PocketChem UA is the first ... take up valuable lab bench space. ... the variability in results between operators ... on every run, corrects for ambient ...
Medicine Products: